Cargando…
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan
We compared a standard antihypertensive losartan treatment with a pharmacogenomics-guided rostafuroxin treatment in never-treated Caucasian and Chinese patients with primary hypertension. Rostafuroxin is a digitoxigenin derivative that selectively disrupts the binding to the cSrc-SH2 domain of mutan...
Autores principales: | Citterio, Lorena, Bianchi, Giuseppe, Scioli, Giuseppe A., Glorioso, Nicola, Bigazzi, Roberto, Cusi, Daniele, Staessen, Jan A., Cavuto, Silvio, Ferrandi, Mara, Lanzani, Chiara, Li, Xiaoyi, Lau, Lit-Fui, Chiang, Chern-En, Wang, Tzung-Dau, Wang, Kang-Ling, Ferrari, Patrizia, Manunta, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159753/ https://www.ncbi.nlm.nih.gov/pubmed/33649520 http://dx.doi.org/10.1038/s41397-021-00214-y |
Ejemplares similares
-
Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin
por: Staessen, Jan A, et al.
Publicado: (2011) -
Different antihypertensive and metabolic responses to rostafuroxin in undernourished and normonourished male rats: Outcomes on bodily Na(+) handling
por: Pereira‐Acácio, Amaury, et al.
Publicado: (2023) -
Dissecting the Polygenic Basis of Primary Hypertension: Identification of Key Pathway-Specific Components
por: Maj, Carlo, et al.
Publicado: (2022) -
The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
por: Andrade-Sierra, Jorge, et al.
Publicado: (2022) -
Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases
por: Simonini, Marco, et al.
Publicado: (2018)